Efficacy, Tolerability and Safety of Azilect in Subjects With Progressive Supranuclear Palsy

NCT01187888 · clinicaltrials.gov ↗
PHASE3
Phase
TERMINATED
Status
44
Enrollment
OTHER
Sponsor class

Stopped IMP used off label by phys. in pat. with PSP. Thus no more eligible patients were available for the study(pre-treatm.with Rasagiline=exclusion criterion

Conditions

Interventions

Sponsor

Prof. Dr. Stefan Lorenzl

Collaborators